logo

Rumi Scientific

Rumi Scientific's mission is to fast-track the early stage of drug discovery using our predictive models of the human brain for therapeutic success. Many neurodevelopmental diseases do not have treatments due to a lack of a-priori knowledge of the underlying biology. Rumi Scientific's technology is able to model these diseases to help enable the discovery of new targets and drugs, de-risking the current failure-prone cumbersome approach.
For inquiries, please contact us at
E-mail: info@rumiscientific.com
mobile-logo
 

Videos

Ignacio Munoz-Sanjuan speaks about Rumi's platform and Huntington's disease therapeutic program

Ignacio Munoz-Sanjuan, PhD and CEO of Rumi Scientific, speaks at the 2025 PBSS Symposium “Frontiers in Neuroscience: Emerging Biology and Therapeutics”, which took place on July 22, 2025.

Fast-Tracking Drug Discovery for Rare Diseases

Rumi Scientific de-risks drug discovery in order to help predict therapeutic success from a pre-clinical stage. Our powerful and patent-protected HTS standardized organoid platform mimics the development of human organs, at high-speed. When combined with our artificial intelligence algorithm, we have unprecedented ability to identify compounds that have reversed diseased cells back to health, thus predicting the therapeutic effect a drug could have on a human’s diseased tissues. Learn more at www.rumiscientific.com! Follow us on LinkedIn: https://www.linkedin.com/company/rumi-scientific Follow us on Twitter @RumiSci: https://twitter.com/rumisci

Early neural induction 'neuroloid' grown on micropattern substrate

The video shows the neuroloid organoid model of early human development using the stem cell RUES2 line; movie shows the major early epithelial derivatives labeled by tissue-specific markers: Pax6 for the emerging neural tissue, Sox10 for the neural crest, TFAP2A for the epidermal ectoderm and Six1 for the nascent placodal tissues. Nuclei are labeled with DAPI staining.Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Seaver Autism Center's Advances in Autism Conference

Fred Etoc, Ph.D. and Chief Scientific Officer at Rumi Scientific, spoke at the Seaver Autism Center’s Advances in Autism Conference at the NYC Academy of Medicine, on May 6, 2025.

I would like to learn about Rumi Scientific’s novel discoveries to treat genetic diseases.


YES, TELL ME MORE